Lilly has signed a deal with AI drug developer Insilico that’s worth $115 million up front and approximately $2.75 billion in biobucks ...

Credible nutrition educators and scientists need to be closely involved as medical schools add more instruction on nutrition.

Infant formula safety, updating labels, defining ultraprocessed foods, and expanding inspections of processing plants are ...

The Food and Drug Administration approved on Thursday a gene therapy for severe leukocyte adhesion deficiency type 1 (LAD-1), ...

In today's Readout newsletter, how China's biotech boom is rewriting everything and how an NIH crackdown is disrupting global ...

A proposal in the Tennessee legislature could force CVS Health to sever a core piece of its business model or exit the state ...

This intervention improves patient safety, clinician well-being, and hospital finances simultaneously — a rare alignment of ...

A new paper shows that women, particularly those early in their careers, have been disproportionately affected by NIH grant ...

CMS wants “to turn this shoddy patchwork of care into a seamless tapestry,” write CMS Administrator Mehmet Oz and Center for ...

How the fight over ICE could pave the way for health reforms. Republicans are considering using a special budget process ...

The Trump administration claims there's widespread fraud in home-based care, but officials haven't offered any evidence.

Novo Nordisk appointed Poul Weihrauch, chief executive officer of the Mars candy company, as board observer as it tries to ...